(Total Views: 573)
Posted On: 10/12/2021 3:05:52 PM
Post# of 79

$EYPT News Article - EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual Meeting https://marketwirenews.com/news-releases/eyep...25407.html


My Twitter: WhyteStocks